Advances in targeted therapy for acute myeloid leukemia

Acute myeloid leukemia (AML) is a clonal malignancy characterized by genetic heterogeneity due to recurrent gene mutations. Treatment with cytotoxic chemotherapy has been the standard of care for more than half of a century. Although much progress has been made toward improving treatment related mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jifeng, Jiang, Peter Y. Z., Sun, Hao, Zhang, Xia, Jiang, Zhongxing, Li, Yingmei, Song, Yongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238648/
https://www.ncbi.nlm.nih.gov/pubmed/32477567
http://dx.doi.org/10.1186/s40364-020-00196-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238648/
https://www.ncbi.nlm.nih.gov/pubmed/32477567
http://dx.doi.org/10.1186/s40364-020-00196-2

Ejemplares similares